Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.89 USD | 0.00% | +24.68% | +211.20% |
21/05 | Lexaria Bioscience Secures New Hypertension, Epilepsy Patents in US; Shares Rise | MT |
17/05 | Lexaria Bioscience Corp. Announces Dosing Begins in Comprehensive GLP-1 Animal Study | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+211.20% | 5.01Cr | |
+42.60% | 75TCr | |
+33.05% | 60TCr | |
-5.74% | 36TCr | |
+17.79% | 33TCr | |
+3.37% | 28TCr | |
+16.81% | 24TCr | |
+8.53% | 21TCr | |
-4.54% | 21TCr | |
+6.74% | 16TCr |
- Stock Market
- Equities
- LEXX Stock
- News Lexaria Bioscience Corp.
- Lexaria Bioscience Appoints Mike Shankman as CFO